George Clinical Scientific Leader to Give Talks on Text Messaging Platform That Improves Health Outcomes and Mobilizes Clinical Research
Sydney, Australia, November 16, 2016 (Newswire.com) - Google Impact Challenge winner and George Clinical scientific leader, Professor Clara Chow will follow her presentation High-Touch, Low-Tech: The Power of Texting to Improve Health at the American Heart Association conference in New Orleans with a once-off talk on the evening of the 16th of November in the San Francisco Bay Area. Professor Chow will focus her talk on the power of texting to improve health and clinical trial outcomes.
Professor Chow and her colleagues at George Clinical’s parent organisation, The George Institute for Global Health were recently announced winners of the Google Impact Challenge, with their “TEXTCARE” application. With a top prize of AUD$750,000, Professor Chow and her colleagues plan to use its proven text messaging platform to tackle chronic disease on a global scale.
“An SMS has the power to save millions of lives,” Professor Clara Chow said. “We have over five years of evidence to prove that this relatively low-tech and inexpensive method of communication with patients can have a long-lasting impact on their lifestyle and their adherence to medication. As such, TEXTCARE has the potential to significantly improve a patient’s longevity and quality of life.”
"We have over five years of evidence to prove that this relatively low-tech and inexpensive method of communication with patients can have a long-lasting impact on their lifestyle and their adherence to medication. As such, TEXTCARE has the potential to significantly improve a patient's longevity and quality of life."
Scientific Leadership is a unique service offered by George Clinical that utilizes the expertise and networks of the George Institute to identify the best clinical trial sites and boost recruitment. George Clinical’s scientific leaders share a passion for innovative and cost effective solutions to improve clinical trial design.
“We are regularly impressed by the innovative, evidence-based solutions to chronic disease management generated by our Scientific Leaders,” Dr Marisa Petersen, Executive Director of George Clinical said. “TEXTCARE is a platform that has been shown to improve compliance with medication and engagement with physicians. This text messaging platform is easily applicable to support patient retention particularly in long term outcomes studies – and the evidence is there to show it works”.
The George Institute and George Clinical have a highly successful, symbiotic relationship. The Institute provides the expertise of its high-calibre researchers, such as Professor Clara Chow. George Clinical provides a world-class full service CRO, delivering clinical trials to the highest standards for small and large pharmaceutical, medical device and biotech companies. George Clinical also provides its services to Institute trials and a majority of George Clinical’s profits are donated to the Institute in order to support its ongoing body of global research.
“Our trials have already shown that this technology works,” Professor Chow said. "People who receive these personalised texts are more likely to take their medications correctly, stop smoking and start exercising, placing them at much lower risk of suffering another heart attack or stroke.”
To express your interest in attending Professor Chow’s talk, please contact Kristine Afansev, George Clinical’s Business Development Manager by phone +1 858-220-1597 or email email@example.com. Spaces are limited so secure your place today.
About George Clinical
George Clinical is a leading independent clinical research organisation (CRO) in Asia with over 200 staff operating in 11 countries. George Clinical provides the full range of clinical trial services to pharmaceutical, medical device and biotech customers, for all trial phases, registration and post-marketing trials. George Clinical combines scientific and clinical leadership with expert trial delivery capability to create a distinctive world-class service. George Clinical’s parent organization, The George Institute for Global Health, is a leader in chronic disease research, with a global network of experts with whom George Clinical engages. George Clinical delivers an operationally supported, internationally recognized scientific leadership service, providing motivation and engagement to trial investigators at a peer to peer level. George Clinical provides customizable clinical trial excellence from trial design through all aspects of delivery. Our website is: www.georgeclinical.com or follow us on LinkedIn, Facebook and Twitter @george_clinical
About The George Institute for Global Health
The George Institute for Global Health is improving the lives of millions of people worldwide through innovative health research. Working across a broad health landscape, the Institute conducts clinical, population and health system research aimed at changing health practice and policy worldwide. The Institute has a global network of medical and health experts working together to address the leading causes of death and disability worldwide. Established in Australia and affiliated with The University of Sydney, the Institute today also has offices in China, India and the United Kingdom, and is also affiliated with Peking University Health Science Centre, the University of Hyderabad and the University of Oxford. Follow us on Facebook at and on Twitter @georgeinstitute
Source: George Clinical